Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a ten percent owner of Natures Sunshine Products Inc. (NASDAQ:NATR), has recently sold a portion of its shares in the company. According to a recent SEC filing, the sales occurred over several transactions from October 1 to October 14, 2024. The shares were sold at prices ranging from $13.12 to $13.54 per share, amounting to a total sale value of $145,188.
The transactions involved multiple sales, with shares sold on various dates including October 1, 8, 9, 10, 11, and 14. Following these transactions, Fosun Pharmaceutical now holds 66,467 shares of Natures Sunshine Products indirectly through its wholly-owned subsidiary, Fosun Industrial Co., Limited.
In other recent news, Nature's Sunshine Products, Inc. has made a significant leadership change, appointing Kevin Fuller as the new Global Chief Marketing Officer (CMO). Fuller, with over two decades of marketing experience in high-performance organizations, is set to contribute to the company's brand and customer growth strategies. Prior to this appointment, he held positions at Helo Health and MacuVu Macular Health, demonstrating a successful track record in the industry. CEO Terrence Moorehead has expressed confidence in Fuller's capabilities, highlighting his extensive experience in the dietary supplement industry. This recent development is part of Nature's Sunshine's ongoing efforts to expand its market share and innovate within the natural health sector. Notably, Fuller's educational background includes an MBA from Brigham Young University and a B.S. in Biology from the University of Utah. His appointment is effective from September 23, 2024.
InvestingPro Insights
While Shanghai Fosun Pharmaceutical has reduced its stake in Natures Sunshine Products Inc. (NASDAQ:NATR), recent data from InvestingPro reveals some intriguing aspects of the company's financial health and market performance. Despite the recent insider selling, NATR boasts a perfect Piotroski Score of 9, indicating strong financial stability. This score, coupled with the fact that the company holds more cash than debt on its balance sheet, suggests a solid financial foundation.
InvestingPro data shows that NATR's market capitalization stands at $240.97 million, with a price-to-earnings ratio of 16.04. The company's revenue for the last twelve months as of Q2 2024 was $441.68 million, with a modest growth of 2.14%. Notably, NATR maintains impressive gross profit margins of 71.87%, which aligns with an InvestingPro Tip highlighting the company's "impressive gross profit margins."
However, investors should note that NATR's stock price has experienced significant declines recently. InvestingPro data indicates a 17.39% drop over the past three months and a more substantial 29.77% decrease over six months. This price movement correlates with an InvestingPro Tip stating that the "stock has taken a big hit over the last six months."
For those interested in a deeper analysis, InvestingPro offers 12 additional tips on Natures Sunshine Products, providing a comprehensive view of the company's prospects and potential risks. These insights can be particularly valuable given the recent insider selling activity and the stock's recent performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.